(Q40565395)

21 September 2017

title

Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey (English)

1 reference

multicenter clinical trial

21 September 2017

main subject

0 references

author name string

Francisco Alvarez-Lerma

1

1 reference

21 September 2017

Joan Nolla

2

1 reference

21 September 2017

Mercedes Palomar

3

1 reference

21 September 2017

María A León

4

1 reference

21 September 2017

language of work or name

Spanish

0 references

publication date

1 February 2003

1 reference

Infectious Diseases and Clinical Microbiology

21 September 2017

published in

1 reference

21 September 2017

volume

21

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

83-88

1 reference

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Candida infection in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Clinical significance of Candida isolated from peritoneum in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Candida colonization and subsequent infections in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Risk factors for hospital-acquired candidemia. A matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

High-dose therapy with fluconazole > or = 800 mg day-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

The exciting future of antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2803%2972888-2

7 January 2021

10.1016/S0213-005X(03)72888-2

Identifiers

DOI

1 reference

21 September 2017

1 reference